Patent Expiry
GILD: LETAIRIS: recorded patent 9549926 expiry
October 14, 2031 · AMBRISENTAN. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- October 14, 2031
- Company
- GILEAD SCIENCES, INC. (GILD)
- Drug
- AMBRISENTAN
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
LETAIRIS: recorded patent 9549926 expiry
Orange Book application NDA022081, product 001, listed patent 9549926 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Company
- GILEAD SCIENCES, INC. (GILD)
- Drug
- AMBRISENTAN